Transcatheter edge-to-edge mitral valve repair in patients with mitral annulus calcification

Estefanía Fernández-Peregrina1,2, Isaac Pascual3, Xavier Freixa4

  • 1Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Abstract

Insights

Transcatheter edge-to-edge repair using MitraClip is safe and effective for patients with mitral regurgitation and mitral annulus calcification. This treatment shows good clinical and echocardiographic outcomes at one year.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Mitral annulus calcification (MAC) is common in mitral regurgitation (MR) patients, associated with poor outcomes.
  • Transcatheter edge-to-edge repair (TEER) is an alternative, but evidence in MAC patients is limited.

Purpose of the Study:

  • To evaluate the safety, efficacy, and durability of MitraClip implantation.
  • To analyze outcomes in patients with severe MR and moderate/severe MAC compared to those without/mild MAC.

Main Methods:

  • Retrospective analysis of 61 patients with MAC and 791 patients without/mild MAC undergoing MitraClip.
  • Comparison of procedural success, complication rates, and one-year clinical/echocardiographic outcomes.

Main Results:

  • Similar procedural success (91.8% MAC vs 95.1% NoMAC) and low complication rates.
  • At one year, 90.6% MAC patients had MR grade ≤2; 80% in both groups were NYHA Class ≤II.
  • Higher one-year mortality in MAC patients (19.7% vs 11.3%), with no difference in cardiovascular mortality.

Conclusions:

  • MitraClip is safe and feasible for selected patients with moderate/severe MAC and severe MR.
  • The procedure yields good clinical and echocardiographic results at one-year follow-up.
  • TEER offers a viable treatment option for this high-risk population.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
50
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
59
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
47
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
87
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
74
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
75